Furthermore, it was found that there were increased proportions of tumor-infiltrating CD4+CD25+ T cells in patients with early stage NSCLC, and these CD4+CD25+ T cells were found to secrete immunosuppressive cytokine TGF-β, which may play a role in cancer progression [55, 56]. This evidence concerns the gene TGFB1 and neoplasm.